0001821825-24-000011.txt : 20240301
0001821825-24-000011.hdr.sgml : 20240301
20240301162413
ACCESSION NUMBER: 0001821825-24-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240228
FILED AS OF DATE: 20240301
DATE AS OF CHANGE: 20240301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WALSH MATTHEW M
CENTRAL INDEX KEY: 0001269428
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40235
FILM NUMBER: 24710247
MAIL ADDRESS:
STREET 1: ALLERGAN
STREET 2: 5 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Organon & Co.
CENTRAL INDEX KEY: 0001821825
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 464838035
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30 HUDSON STREET
STREET 2: FL 33
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302
BUSINESS PHONE: 551-430-6000
MAIL ADDRESS:
STREET 1: 30 HUDSON STREET
STREET 2: FL 33
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302
4
1
wk-form4_1709328243.xml
FORM 4
X0508
4
2024-02-28
0
0001821825
Organon & Co.
OGN
0001269428
WALSH MATTHEW M
C/O ORGANON & CO.
30 HUDSON STREET, FLOOR 33
JERSEY CITY
NJ
07302
0
1
0
0
Chief Financial Officer
0
Common Stock
2024-02-28
4
M
0
33044
A
85455
D
Common Stock
2024-02-28
4
F
0
11393
18.04
D
74062
D
Restricted Stock Units
2024-02-28
4
M
0
33044
0
D
2023-12-31
2023-12-31
Common Stock
33044
0
D
Each Restricted Stock Unit converts into one share of Organon & Co. common stock.
As previously reported, these Restricted Stock Units vested on December 31, 2023, and shares of Organon & Co. common stock were distributed to the Reporting Person on February 28, 2024.
/s/ Faye C. Brown, as Attorney-in-Fact for Matthew M. Walsh
2024-03-01